AREV Life Sciences Global Corp. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was CAD 0.010188 million compared to CAD 0.043188 million a year ago. Net loss was CAD 0.772944 million compared to CAD 0.69526 million a year ago.
For the six months, sales was CAD 0.018815 million compared to CAD 0.086528 million a year ago. Net loss was CAD 1.28 million compared to CAD 1.27 million a year ago.